In relation to survival, the main prognostic factors are age, tumor stage (pTN), mucin presence, differentiation grade, Kras oncogene mutation, PCI, adjuvant chemotherapy treatment type, and performance of cytoreduction surgery and HIPEC. The gene discussed is KRAS; the disease is neoplasm.